Patents for C07C 279 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups (5,394) |
---|
03/21/2001 | CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound |
03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |
03/20/2001 | US6204294 IL-8 receptor antagonists |
03/15/2001 | WO2001017977A1 1,3,5-triazines as herbicides |
03/15/2001 | WO2001017948A1 Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same |
03/15/2001 | CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents |
03/14/2001 | EP1083166A1 Novel substituted guanidine derivatives and process for producing the same |
03/14/2001 | CN1287118A Method of preparing creatine or its hydrate |
03/08/2001 | WO2000072800A3 Il-8 receptor antagonists |
03/07/2001 | CN1062859C Substd 1-naphthoyl guanidines, their preparing method, use and drug contg. them |
03/07/2001 | CN1062858C Phenyl-substd alkenylcarboguanidides carrying perfluoroalkyl groups, process for their preparation, their use as medicament and medicines |
03/06/2001 | US6197214 Ammonium thiosulfate complex of gold or silver and an amine |
03/01/2001 | WO2001014324A1 Selective inhibitors of the urokinase plasminogene activators |
03/01/2001 | WO2001014323A1 Method for producing 1-methyl-3-nitroguanidine |
03/01/2001 | DE19940389A1 Selektive Inhibitoren des Urokinase-Plasminogen Aktivators Selective inhibitors of urokinase plasminogen activator |
02/28/2001 | EP1077933A1 Substituted guanidines and diaminonitroethenes, their preparation and use |
02/28/2001 | CN1062555C Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
02/28/2001 | CN1062554C Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound |
02/27/2001 | US6194447 Bis (benzimidazole) derivatives serving as potassium blocking agents |
02/27/2001 | US6194446 Hypoglycemic and hypolipidemic compounds |
02/27/2001 | US6194380 Agents for promoting bone formation |
02/27/2001 | CA2185165C Process for the synthesis of cationic surfactants derived from the condensation of fatty acids with esterified basic-character amino acids and their application as antimicrobial agents |
02/27/2001 | CA2101316C Gnrh analogs |
02/22/2001 | WO2001012634A1 Group(iii)-metal-hydrides with a guanidino-type ligand |
02/22/2001 | DE19939609A1 Pure 1-methyl-3-nitroguanidine preparation in high yield for use as insecticide intermediate, by reacting cyanogen halide with methylamine then ammonium nitrate and dehydrating product |
02/21/2001 | EP1076643A1 Biphenyl derivatives |
02/21/2001 | CN1284950A Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
02/15/2001 | WO2001010849A2 Substituted arylalkylamino-1,3,5-triazines as herbicides |
02/15/2001 | WO2001010841A2 Fluorene derivatives as integrin inhibitors |
02/15/2001 | WO2001010835A1 Antibacterial agents |
02/15/2001 | DE19936633A1 Substituierte Arylalkylamino-1,3,5-triazine Substituted arylalkylamino-1,3,5-triazines |
02/15/2001 | CA2380981A1 Fluorene derivatives |
02/14/2001 | EP0844874A4 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS |
02/14/2001 | CN1284069A Substituted 2,4-diamino-1,3,5-triazines |
02/14/2001 | CN1284060A Novel metalloproteinase inhibitors |
02/14/2001 | CN1284058A Neuroprotective agents |
02/14/2001 | CN1283447A Locally-used weight reducing face-care compsns. |
02/14/2001 | CN1061974C Process for synthesis of guanidine dihydrogen phosphate and guanidine hydrogen phosphate |
02/13/2001 | US6187955 Guanidine derivatives and process for their production |
02/08/2001 | WO2001009096A2 Potassium channel openers |
02/08/2001 | DE19937394A1 Fluorenderivate Fluoro derivatives |
02/08/2001 | CA2378936A1 Potassium channel openers |
02/07/2001 | EP1073650A1 Guanidine derivatives |
02/07/2001 | EP1073623A1 Substituted amino acids as erythropoietin mimetics |
02/07/2001 | EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
02/07/2001 | CN1061648C Antiarrhythmic and cardioprotective substituted indenoyiguanidines |
02/07/2001 | CN1061647C Process for preparing creatine or creatine hydrate |
02/01/2001 | WO1997045137A8 Methods and compositions useful for inhibition of angiogenesis |
01/31/2001 | CN1282316A Substituted cyslopentane and cyclopentene compounds useful as neuraminidase inhibitors |
01/30/2001 | US6180140 Modified amino acids for drug delivery |
01/25/2001 | WO2001005753A1 Diacylhydrazine derivatives |
01/25/2001 | WO2001005752A1 Aminoguanidine bicarbonate with particular properties and method for making same |
01/25/2001 | CA2379041A1 Diacylhydrazine derivatives |
01/24/2001 | EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
01/24/2001 | EP1070046A1 Propanolamine derivatives |
01/18/2001 | WO2001004128A1 Bioavailable chelates of creatine and essential metals |
01/18/2001 | DE19932796A1 Diacylhydrazinderivate Diacylhydrazinderivate |
01/17/2001 | EP1068178A1 NON-PEPTIDE GnRH AGENTS |
01/17/2001 | CN1060764C Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing them |
01/17/2001 | CN1060763C Urea-substituted benzoylguanidines, process for their preparation, and use and pharmaceutical containing them |
01/16/2001 | US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound |
01/16/2001 | US6174887 Amide compounds and use of the same |
01/11/2001 | DE19929993A1 New creatine alpha-ketoglutarate compounds, having synergistic activity e.g. in improving sporting strength and endurance, eliminating blood ammonia or treating liver diseases |
01/10/2001 | CN1279666A NPY antagonists |
01/09/2001 | US6172111 Salt formation; antiobesity and strengthening agents |
01/09/2001 | CA2117483C [(benzodioxan, benzofuran or benzopyran)-alkylamino] alkyl substituted guanidines as selective vascoconstrictors |
01/04/2001 | WO2001000623A1 Method of producing nitroguanidine- and nitroenamine derivatives |
01/04/2001 | WO2001000571A1 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof |
01/04/2001 | WO2001000558A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates |
01/04/2001 | WO2001000206A1 Vla-4 inhibitor compounds |
01/04/2001 | WO2000035868A3 Methods for the synthesis of alpha-hydroxy-beta-amino acid and amide derivatives |
01/04/2001 | CA2377287A1 Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates |
01/04/2001 | CA2377240A1 Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof |
01/04/2001 | CA2369308A1 Vla-4 inhibitor compounds |
01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
12/28/2000 | WO2000078737A2 Aryloxy ethylamino triazines as herbicides |
12/27/2000 | EP1062264A2 Enzyme inhibitors |
12/27/2000 | EP1021099A4 Anti-bacterial amine derivatives |
12/26/2000 | US6166249 Creatine pyruvates |
12/26/2000 | US6166239 Useful during oligonucleotide synthesis to protect nucleobase amines as well as tethered amines used for attaching functional moieties to oligonucleotides. |
12/21/2000 | WO2000076991A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
12/21/2000 | WO2000076517A1 Il-8 receptor antagonists |
12/21/2000 | WO2000076516A1 Il-8 receptor antagonists |
12/21/2000 | DE19927611A1 New aryloxyethylamino-triazine derivatives are used as herbicides, especially for selective control of undesired plant growth in cotton, barley, maize, beet and wheat |
12/21/2000 | CA2377397A1 Il-8 receptor antagonists |
12/21/2000 | CA2374627A1 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
12/20/2000 | EP1060739A1 Slimming cosmetic composition containing L-arginine or a derivative thereof |
12/20/2000 | EP1060175A2 Tryptase inhibitors |
12/20/2000 | EP1060171A2 Tryptase inhibitors |
12/14/2000 | WO2000046187A3 Antizyme modulators and their use |
12/12/2000 | US6160134 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
12/07/2000 | WO2000073258A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same |
12/07/2000 | WO2000072840A1 Il-8 receptor antagonists |
12/07/2000 | WO2000072800A2 Il-8 receptor antagonists |
12/07/2000 | CA2374295A1 Il-8 receptor antagonists |
12/06/2000 | EP0775692B1 Guanidinomethyl cyclohexane carboxylic ester derivative |
12/05/2000 | US6156741 Nervous system disorders |
12/05/2000 | US6156735 Arginine silicate inositol complex and use thereof |
12/05/2000 | CA2188452C Guanidino-substituted compounds |
11/30/2000 | WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY |